December 4, 2020
Consumer, Retail, E-commerce and Leisure, Healthcare
GCA Altium advises on the acquisition of 7days
GCA Altium acted as financial advisor to Chequers Capital on the acquisition of 7days, a leading European supplier of fashionable and innovative workwear for medical professionals.
The company was founded in 1999 in Lotte near Osnabrück, Germany. 7days designs, produces and distributes a wide range of high-quality workwear, from tunics to lab coats, for more than 300,000 customers in the healthcare sector in twelve countries, including Germany, Austria, Switzerland, France, Belgium, the Netherlands and Scandinavia.
7days has a vertically integrated business model with diversified supply chains and sells its products via a fully integrated multi-channel sales approach including catalogue marketing and e-commerce channels.
With the support of Chequers Capital and co-investor Paragon Partners, 7days plans to further accelerate its growth trajectory in Germany and the rest of Europe. 7days will benefit from continuing strong market trends such as the increasing professionalisation of medical workwear and increased hygiene awareness in the wake of the Covid-19 pandemic, which promise future growth potential in a fragmented market.
“The management team around Ulrich Dölken and Carsten Meyer has delivered an impressive growth trajectory over the last years. We are very much looking forward to supporting this expansion in the future, in DACH as well as on a pan-European basis. Also, add-on acquisitions will play a role in growing the company,” commented Sven H. Schulze, Managing Director at Chequers Capital.
Ulrich Dölken and Carsten Meyer, CEO and CFO of 7days Group, added: “With the support of our new partners, Chequers Capital and Paragon Partners, we want to continue to achieve the highest level of customer satisfaction with high-quality workwear for medical professionals. We are pleased to have two strong partners at our side, who will help us further expand our market position in the coming years.”
Terms of the transaction were not disclosed. The transaction is subject to customary approvals from competition authorities.